Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000264438

Medchemexpress LLC Brilaroxazine | 1239729-06-6 | 98.8% | 450.36 g/mol | C22H25Cl2N3O3 | 5 MG
SDP

Catalog No. 5000264438
Encompass_Preferred

Brilaroxazine (RP5063) is an investigational atypical antipsychotic and serotonin-dopamine system modulator supplied for research use. It is offered as a purified solid and as a DMSO solution, intended for preclinical pharmacology, receptor profiling, and in vitro studies.

  • Investigational atypical antipsychotic and dopamine/5-HT modulator.
  • High purity (98.8%).
  • Chemical formula C22H25Cl2N3O3; molecular weight 450.36 g/mol.
  • Available as solid and as a 10 mM solution in DMSO.
  • Suitable for receptor binding, pharmacology, and preclinical studies.
  • Offered in small research pack sizes, including 5 mg.

Catalog No. 50-002-64438 Supplier Medchemexpress LLC Supplier No. HY1091125MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Brilaroxazine (RP5063) is an investigational atypical antipsychotic and serotonin-dopamine system modulator supplied for research use. It is offered as a purified solid and as a DMSO solution, intended for preclinical pharmacology, receptor profiling, and in vitro studies.

  • Investigational atypical antipsychotic and dopamine/5-HT modulator.
  • High purity (98.8%).
  • Chemical formula C22H25Cl2N3O3; molecular weight 450.36 g/mol.
  • Available as solid and as a 10 mM solution in DMSO.
  • Suitable for receptor binding, pharmacology, and preclinical studies.
  • Offered in small research pack sizes, including 5 mg.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.